Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | ACACA | Q13085 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4873757 | 0.94 | KMT2A (0.46) | KDM4EALDH1A1SMN1; SMN2RAB9ANPC1 | |
| SCHEMBL4872104 | 0.92 | KDM4E (0.40) | KDM4EALDH1A1SMN1; SMN2RAB9ANPC1 | |
| SCHEMBL4868356 | 0.91 | MAPT (0.35) | KDM4EALDH1A1SMN1; SMN2RAB9ANPC1 | |
| SCHEMBL4872449 | 0.89 | KMT2A (0.40) | KDM4EALDH1A1SMN1; SMN2RAB9ANPC1 | |
| SCHEMBL4876271 | 0.88 | HPGD (0.31) | ALDH1A1SMN1; SMN2RAB9AKMT2AHPGD | |
| SCHEMBL4874739 | 0.87 | KMT2A (0.36) | KDM4EALDH1A1SMN1; SMN2RAB9ANPC1 | |
| SCHEMBL4868467 | 0.85 | KDM4E (0.44) | KDM4EALDH1A1SMN1; SMN2RAB9ANPC1 | |
| SCHEMBL3938012 | 0.85 | KCNH2 (0.35) | SMN1; SMN2RAB9AHPGDMAPTLMNA | |
| SCHEMBL4874047 | 0.85 | TP53 (0.44) | KDM4EALDH1A1SMN1; SMN2RAB9ANPC1 | |
| SCHEMBL4874071 | 0.85 | ALDH1A1 (0.46) | KDM4EALDH1A1SMN1; SMN2RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080051384-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. | 2008-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051384-A1 | ANTIVIRAL AGENTS | EIF2AK2, MAVS, ZC3HAV1 | KDM4E 3075/4885ALDH1A1 1357/4885SMN1; SMN2 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.